ArticleOncoimmunology
NK cell activation and recovery of NK cell subsets in lymphoma patients after obinutuzumab and lenalidomide treatment.
Dang-Nghiem Vo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
28 papers cite it
trialcites it